Glioblastoma drugs

Glioblastoma, previously known as glioblastoma multiforme (GBM), is the most aggressive and most common type of cancer that originates in the brain

We support the development of new drugs and other effective therapies for glioblastoma. Because each glioblastoma is different, it is likely that no one drug

This booklet will focus on the treatment of glioblastoma (also called glioblastoma multiforme), the most common type of malignant brain tumor. The standard of care for glioblastoma is surgery, followed by radiation and chemotherapy. By removing or shrinking the glioblastoma tumor, doctors relieve the pressure on the brain these tumors can cause.

The mission of the Glioblastoma Foundation is to transform the standard of care for glioblastoma. We support the development of new drugs and other effective therapies for glioblastoma. Because each glioblastoma is different, it is likely that no one drug will work for everyone, and any therapies for glioblastoma will need to be targeted.

Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer drugs with potent anti-glioblastoma activity.

Study Identifies a Potential Target for Glioblastoma Drugs. Glioblastoma (GBM), a highly aggressive type of

UCSF scientists have found that brain cancer glioblastoma can cause This makes us hopeful that combining gabapentin with other glioblastoma

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients Patients with glioblastoma-;the deadliest type

drugs that target the growth pathways of glioblastomas. Combinations of brain cancers and finding effective new treatment modalities, including glioblastoma